Literature DB >> 16645274

Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia.

H Wehr1, M Bednarska-Makaruk, W Łojkowska, A Graban, D Hoffman-Zacharska, A Kuczyńska-Zardzewiały, J Mrugała, M Rodo, A Bochyńska, A Sułek, D Ryglewicz.   

Abstract

In 229 patients with dementia and in 144 control subjects, polymorphisms of apolipoprotein E (ApoE), low-density-lipoprotein (LDL)-receptor-related protein, alpha(2)-macroglobulin, interleukin (IL) 1beta, angiotensin-converting enzyme and of methylene tetrahydrofolate reductase genes were investigated. In plasma, antibodies against Chlamydia pneumoniae and lipids were determined. Dementia was classified as probable Alzheimer's disease (AD), probable dementia of vascular origin (VaD) and mixed dementia (MD). An association of the disease with ApoE and IL-1beta polymorphism and increased levels of LDL cholesterol were observed in AD and in MD but not in VaD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645274     DOI: 10.1159/000092845

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  12 in total

1.  The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study.

Authors:  K S Benke; M C Carlson; B Q Doan; J D Walston; Q L Xue; A P Reiner; L P Fried; D E Arking; A Chakravarti; M D Fallin
Journal:  Exp Gerontol       Date:  2011-09-24       Impact factor: 4.032

2.  Interleukin-1α, interleukin-1β and tumor necrosis factor-α genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective study.

Authors:  Diego Albani; Mauro Tettamanti; Sara Batelli; Letizia Polito; Sabrina Dusi; Eleonora Ateri; Gianluigi Forloni; Ugo Lucca
Journal:  Age (Dordr)       Date:  2011-04-21

3.  The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia.

Authors:  Marianna Trebunová; Eva Slabá; Viera Habalová; Zuzana Gdovinová
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

4.  Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis.

Authors:  Hai Yuan; Qing Xia; Pingping Ge; Shaowei Wu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

5.  The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology.

Authors:  James A Mortimer; David A Snowdon; William R Markesbery
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

6.  Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Authors:  Xiaoliu Dong; Li Zhang; Qingling Meng; Qiuyan Gao
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

Review 7.  Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis.

Authors:  Vandana Rai
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

8.  Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.

Authors:  Xue-bin Wang; Ning-hua Cui; Jie Yang; Xue-ping Qiu; Jia-jia Gao; Na Yang; Fang Zheng
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 9.  Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease.

Authors:  Barbara Troesch; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-12-10       Impact factor: 5.717

10.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.